MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
41 hedge funds and large institutions have $49.5M invested in Merrimack Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less call options, than puts
Call options by funds: $276K | Put options by funds: $1.1M
Holders
41
Holding in Top 10
1
Calls
$276K
Puts
$1.1M
Top Buyers
| 1 | +$1.38M | |
| 2 | +$1.04M | |
| 3 | +$258K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$239K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$96.4K |
Top Sellers
| 1 | -$336K | |
| 2 | -$76K | |
| 3 | -$71.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$54.7K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$39.2K |